Invention Grant
- Patent Title: Chimeric antigen receptors targeting B-cell maturation antigen
-
Application No.: US17117368Application Date: 2020-12-10
-
Publication No.: US11359204B2Publication Date: 2022-06-14
- Inventor: James N. Kochenderfer
- Applicant: The United States of America,as represented by the Secretary,Department of Health and Human Services
- Applicant Address: US MD Bethesda
- Assignee: The United States of America,as represented by the Secretary,Department of Health and Human Services
- Current Assignee: The United States of America,as represented by the Secretary,Department of Health and Human Services
- Current Assignee Address: US MD Bethesda
- Agency: Leydig, Voit & Mayer
- Main IPC: C12N15/62
- IPC: C12N15/62 ; C07K14/705 ; C07K14/725 ; C07K16/28 ; C07K16/18 ; A61K48/00 ; A61K39/00
Abstract:
The invention provides an isolated and purified nucleic acid sequence encoding a chimeric antigen receptor (CAR) directed against B-cell Maturation Antigen (BCMA). The invention also provides host cells, such as T-cells or natural killer (NK) cells, expressing the CAR and methods for destroying multiple myeloma cells.
Public/Granted literature
- US20210095295A1 CHIMERIC ANTIGEN RECEPTORS TARGETING B-CELL MATURATION ANTIGEN Public/Granted day:2021-04-01
Information query
IPC分类:
